Connect with us

COVID-19

Rep. Paul Gosar introduces bill to end vaccine manufacturer immunity from injury lawsuits

Published

5 minute read

From LifeSiteNews

By Calvin Freiburger

Rep. Paul Gosar’s End the Vaccine Carveout Act would eliminate the general immunity vaccine manufacturers enjoy from vaccine injury civil suits under the federal National Childhood Vaccine Injury Act of 1986.

Republican U.S. Rep. Paul Gosar of Arizona introduced a bill Thursday that would end pharmaceutical companies’ shield against liability for any potential harmful effects of the vaccines they manufacture.

 H.R. 9828, the End the Vaccine Carveout Act, would allow individuals to “bring a civil action against a vaccine administrator or manufacturer in a State or Federal court for damages arising from such injury or death,” according to an advance copy of the text provided to LifeSiteNews.

This would eliminate the general immunity vaccine manufacturers enjoy under the federal National Childhood Vaccine Injury Act of 1986, which instead establishes a compensation program for victims. Gosar’s bill allows for civil actions to be pursued regardless of whether a victim has filed a petition with the program, although ultimately receiving an award from one would invalidate a petition to the other.

“Government bureaucrats and scientists responsible for approving vaccines are in bed with Big Pharma, often owning pharmaceutical stocks, serving as consultants and receiving lucrative contracts from pharmaceutical companies that pressure them to produce favorable results which is in direct violation of federal law,” Gosar said in a press release. “Big Pharma doesn’t deserve a get-out-of-jail-free card for injuries caused by their harmful vaccines.”

The question of vaccine safety has become more mainstream in recent years due to the controversy surrounding the COVID-19 vaccines, which were developed and reviewed in a fraction of the time  vaccines usually take under the Trump administration’s Operation Warp Speed initiative.

large body of evidence identifies significant risks to the COVID vaccines. Among it, the federal Vaccine Adverse Event Reporting System (VAERS) reports 37,910 deaths, 217,931 hospitalizations, 21,917 heart attacks, and 28,602 myocarditis and pericarditis cases as of September 6, among other ailments. U.S. Centers for Disease Control and Prevention (CDC) researchers have recognized a “high verification rate of reports of myocarditis to VAERS after mRNA-based COVID-19 vaccination,” leading to the conclusion that “under-reporting is more likely” than over-reporting.

An analysis of 99 million people across eight countries published February in the journal Vaccine  “observed significantly higher risks of myocarditis following the first, second and third doses” of mRNA-based COVID vaccines, as well as signs of increased risk of “pericarditis, Guillain-Barré syndrome, and cerebral venous sinus thrombosis,” and other “potential safety signals that require further investigation.” In April, the CDC was forced to release by court order 780,000 previously undisclosed reports of serious adverse reactions, and a study out of Japan found “statistically significant increases” in cancer deaths after third doses of mRNA-based COVID-19 vaccines, and offered several theories for a causal link.

In Florida, an ongoing grand jury investigation into the vaccines’ manufacturers is slated to release a highly anticipated report on the shots, and a lawsuit by the state of Kansas has been filed accusing Pfizer of misrepresentation for calling the shots “safe and effective.”

According to the Congressional Research Service (CRS), the PREP Act empowers the federal government to “limit legal liability for losses relating to the administration of medical countermeasures such as diagnostics, treatments, and vaccines.” Near the beginning of the 2020 COVID-19 outbreak, the Trump administration invoked the Act in declaring the virus a “public health emergency.”

Under this “sweeping” immunity, CRS explained, the federal government, state governments, “manufacturers and distributors of covered countermeasures,” and licensed or otherwise-authorized health professionals distributing those countermeasures are shielded from “all claims of loss” stemming from those countermeasures, with the exception of “death or serious physical injury” brought about through “willful misconduct,” a standard that, among other hurdles, requires the offender to have acted “intentionally to achieve a wrongful purpose.”

Many hope that by going after Big Pharma for misrepresentations surrounding their products rather than the products themselves, efforts like the Kansas suit can circumvent that hurdle to impose consequences on those responsible for the shots.

Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.

Follow Author

COVID-19

WATCH: Big Pharma scientist admits COVID shot not ‘safe and effective’ to O’Keefe journalist

Published on

From LifeSiteNews

By Doug Mainwaring

‘None of that stuff was safe and effective. We didn’t do the typical tests,’ Joshua Rys of Johnson & Johnson said to one of James O’Keefe’s undercover journalists.

A lead scientist for a global pharmaceutical firm disclosed on hidden camera that his firm’s COVID-19 vaccine underwent rushed testing, lacked research, and admitted that, in direct contradiction to the Biden administration’s constant refrain, the drug was not “safe and effective.”

“None of that stuff was safe and effective. We didn’t do the typical tests,” said Joshua Rys, a lead regulatory affairs scientist for Johnson & Johnson (J&J), not realizing that he was being filmed by one of James O’Keefe’s undercover journalists.

Rys explained that normally a new drug undergoes an extended period of testing, including human trials, but the COVID-19 vaccine circumvented those safety measures in order to rush the product to the public.

“This was just, ‘Let’s test it on some lab-rat models, analyze and see if it works,” said Rys, “and just throw it to the wind and see what happens.”

“I’m sure somebody is going to get sued for that stuff, eventually,” he predicted.

“Do you have any idea [of] the lack of research that was done on those products?” asked the J&J lead scientist.

“People wanted it. We gave it to them,” said Rys.

O’Keefe later approached Rys to ask what led him to tell a total stranger that his product was not safe and effective, but Rys evaded O’Keefe and his probing. 

O’Keefe explained that the work of his O’Keefe Media Group (OMG) undercover journalists is crucial because, he claimed, up to 80 percent of the revenue cable and other news organizations derive from ads comes from Big Pharma.

Continue Reading

COVID-19

Japan disposes $1.6 billion worth of COVID drugs nobody used

Published on

From LifeSiteNews

By Calvin Freiburger

The nation’s health ministry has already trashed 2 million doses of PaxlovidPACK and Lagevrio, and will dispose of 1.77 million doses of Xocova by the end of February 2026.

Japan is disposing of $1.6 billion worth of COVID-19 drugs that went unused and are now expired in a dramatic disconnect between government projections and reality.

The Japanese Broadcasting Corporation reported that the nation’s health ministry has already trashed 1.75 million patients’ worth of PaxlovidPACK and 780,000 patients’ worth of Lagevrio doses, and will dispose of 1.77 million patients’ worth of Xocova by the end of February 2026.

The government had been required by law to purchase enough oral COVID drugs for 5.6 million people, to be distributed free of charge through May 2023, at which point the virus was downgraded to the same threat level as normal seasonal influenza. But 2.5 million, a little under half the supply, remained unused by the time they hit their expiration dates.

The Star added that the value of the destroyed drugs is estimated to be roughly 240 billion yen, or 1.6 billion US dollars.

Across the world, governments took drastic action to counter the COVID pandemic, based in large part on exaggerated assumptions about the virus’s transmissibility and threat to non-elderly individuals without comorbidities. A large body of evidence has found that mass restrictions on personal and economic activity undertaken in 2020 and part of 2021 caused far more harm than good in terms of personal freedom and economics as well as public health, and that lives could have been saved through far less burdensome methods, such as the promotion of established therapeutic drugs, narrower protections focused on those most at risk (such as the elderly and infirm), and increasing vitamin D intake.

In Florida, the first report by a grand jury impaneled by Republican Gov. Ron DeSantis determined that lockdowns did more harm than good, that masks were ineffective at stopping COVID transmission, that COVID was “statistically almost harmless” to children and most adults, and that it is “highly likely” that COVID hospitalization numbers were inflated.

Much like the controversial COVID vaccines, concerns were raised about the safety and effectiveness of COVID therapeutics such as Paxlovid and Lagevrio as well.

In May, former Japanese minister of internal affairs and communications Kazuhiro Haraguchi announced he had cancer, and said testing of the lesions linked it to spike proteins from the COVID-19 vaccine he had received two years before.

Continue Reading

Trending

X